Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 2, 2006, Pages 313-319

  Vieth, M ^a   Kulig, M ^b   Leodolter, A ^c   Naucler E ^d   Jaspersen, D ^e   Labenz, J ^f   Meyer Sabellek, W ^g   Lind, T ^d   Willich, S ^b   Malfertheiner, P ^c   Stolte, M ^a  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d ASTRAZENECA R AND D   (Sweden)

^e KLINIKUM FULDA   (Germany)

^f Ev Jung Stilling Krankenhaus   (Germany)

^g ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

ARTICLE; BASAL CELL; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SQUAMOUS EPITHELIUM;

EID: 33644911449     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02752.x     Document Type: Article

References (32)

1. Sonnenberg A Lepsien G Müller-Lissner SA Koelz HR Siwert JR Blum AL When is esophagitis healed? Esophageal endoscopy, histology and function before and after cimetidine treatment Dig Dis 1982 27 297 302
2. Weinstein WM Bogoch ER Bowes KL The normal human esophageal mucosa: a histological reappraisal Gastroenterology 1975 68 40 4
3. Bate CM Keeling PWN O'Morain C et al. Comparison of omeprazole and cimetidine in reflux esophagitis: symptomatic, endoscopic, and histological evaluations Gut 1990 31 968 72
4. Siewert JR Ottenjann R Heilmann K Neiss A Dopfer H Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I. Epidemiology and results of acute therapy Z Gastroenterol 1986 24 381 95
5. Schindlbeck NE Wiebecke B Klauser AG Vorderholzer WA Müller-Lissner SA Diagnostic value of histology in non-erosive gastro-esophageal reflux disease Gut 1996 39 151 4
6. Plein K Stolte M Fuchs W Funken C Hotz J Vergleichende Untersuchung der Wirkung von Lansoprazol und Ranitidin auf die Abheilung der akuten Refluxösophagitis Leber Magen Darm 1998 28 24 32
7. Stolte M Vieth M Schmitz JM Alexandirdis T Seifert E Effects of long-term treatment with proton pump inhibitors in gastro-esophageal reflux disease on the histological findings in the lower esophagus Scand J Gastroenterol 2000 35 1125 30
8. Kulig M Leodolter A Vieth M et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative Aliment Pharmacol Ther 2003 18 767 76
9. Kulig M Nocon M Vieth M et al. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study J Clin Epidemiol 2004 57 580 9
10. Labenz J Jaspersen D Kulig M et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative Am J Gastroenterol 2004 99 1652 6
11. Labenz J Jaspersen D Kulig M et al. Response to Professor McColl Am J Gastroenterol 2005 100 1621
12. Jaspersen D Kulig M Labenz J et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study Aliment Pharmacol Ther 2003 17 1515 20
13. Malfertheiner P Lind T Willich S et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study Gut 2005 54 746 51
14. Lundell LR Dent J Bennett JR et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification Gut 1999 45 172 80
15. Armstrong D Bennet JR Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement Gastroenterology 1996 111 85 92
16. Dixon MF Genta RM Yardley JH Correa P Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 Am J Surg Pathol 1996 20 1161 81
17. Vieth M Peitz U Labenz J et al. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa Dig Dis 2004 22 196 201
18. Ismail-Beigi F Pope CE Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man Gastroenterology 1974 66 1109 13
19. Ismail-Beigi F Horton PF Pope CE Histological consequences of gastroesophageal reflux in man Gastroenterology 1970 58 163 74
20. Baldi F Bardhan KD Borman PC et al. Lansoprazole maintains healing in patients with reflux esophagitis Gastroenterology 1996 110 A-55
21. Havelund T Laursen LS Skoubo-Kristensen E et al. Omeprazole and ranitidine in treatment of reflux-esophagitis: double blind comparative trial Br Med J 1988 296 89 92
22. Oderda G Dell'Olio D Forni M Farina L Tavasoli K Ansaldi N Treatment of childhood peptic esophagitis with famotidine or alginate-antacid Ital J Gastroenterol 1990 22 346 9
23. Bell NJV Hunt RH Role of gastric acid suppression in the treatment of gastroesophageal reflux disease Gut 1992 33 118 24
24. Hallerbäck B Unge P Carling L et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis Gastroenterology 1994 107 1305 11
25. Dehn TCB Shepherd HA Colin-Jones D Kettlewell MGW Carrol NJH Double blind comparison of omeprazole (40 mg od) versus cimitidine in the treatment of symptomatic erosive reflux esophagitis, assessed endoscopically, histologically and by 24 h pH-monitoring Gut 1990 31 509 13
26. Vieth M Haringsma J Delarive J et al. Red streaks in the oesophagus in patients with reflux disease: is there a histomorphological correlate Scand J Gastroenterol 2001 36 1123 7
27. Kahrilas PJ Falk GW Johnson DA et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: a randomized controlled trial Aliment Pharmacol Ther 2000 14 1249 58
28. Richter JE Kahrilas PJ Johanson J et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized trial Am J Gastroenterol 2001 96 656 65
29. Castell DO Kahrilas PJ Richter JE et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis Am J Gastroenterol 2002 97 575 83
30. Dent J Holloway RH Toouli J Dodds WJ Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux Gut 1988 29 1020 3
31. Schoeman MN Holloway RH Integrity and characteristics of secondary esophageal peristalsis in patients with gastro-esophageal reflux disease Gut 1995 36 499 504
32. Masclee AA de Best AC de Graaf R Cluysenaer OJ Jansen JB Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy Scand J Gastroenterol 1990 25 225 30